Pulmatrix (PULM) Other Working Capital Changes (2019 - 2024)
Pulmatrix (PULM) posted Other Working Capital Changes of -$24000.0 for Q3 2024, up 85.45% sequentially from -$165000.0 in Q2 2024, and up 99.06% YoY from -$12057.0 in Q4 2023.
Pulmatrix (PULM) Other Working Capital Changes (2019 - 2024) Analysis & Trends
Pulmatrix has reported Other Working Capital Changes for 6 years, with the latest figure at -$24000.0 in Q3 2024.
- Quarterly Other Working Capital Changes rose 99.06% year-over-year to -$24000.0 in Q3 2024, while the trailing twelve-month figure through Dec 2024 was -$333000.0 (up 89.05% YoY) and the FY2024 annual result came in at -$333000.0, up 89.05% from the prior year.
- Other Working Capital Changes climbed to -$24000.0 in Q3 2024 per PULM's latest filing, from -$165000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $4.0 million in Q3 2024 and troughed at -$4.0 million in Q1 2024.
- A 5-year average of -$25375.0 and a median of -$134000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The widest YoY moves for Other Working Capital Changes: up 180.66% in 2023, down 503.33% in 2023.
- Over 5 years, Other Working Capital Changes stood at -$152000.0 in 2020, then slumped by 84.87% to -$281000.0 in 2021, then sank by 50.89% to -$424000.0 in 2022, then surged by 180.66% to $342000.0 in 2023, then sank by 107.02% to -$24000.0 in 2024.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$24000.0, -$165000.0, and -$144000.0 for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - |
| 10 | Pulmatrix | 5.62 Mn | 5.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -24,000.00 |
| Sep 30, 2024 | -24,000.00 |
| Sep 30, 2024 | -24,000.00 |
| Jun 30, 2024 | -165,000.00 |
| Jun 30, 2024 | -165,000.00 |
| Jun 30, 2024 | -165,000.00 |
| Mar 31, 2024 | -144,000.00 |
| Mar 31, 2024 | -144,000.00 |
| Mar 31, 2024 | -144,000.00 |
| Dec 31, 2023 | 342,000.00 |
| Dec 31, 2023 | 342,000.00 |
| Dec 31, 2023 | 342,000.00 |
| Sep 30, 2023 | -2.54 Mn |
| Sep 30, 2023 | -2.54 Mn |
| Sep 30, 2023 | -2.54 Mn |
| Jun 30, 2023 | -421,000.00 |
| Jun 30, 2023 | -421,000.00 |
| Jun 30, 2023 | -421,000.00 |
| Mar 31, 2023 | -422,000.00 |
| Mar 31, 2023 | -422,000.00 |